Here's the live share price of Wockhardt along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Wockhardt has gained 26.21% CAGR. Over the past year, the corresponding return has been -4.28%.
Wockhardt’s current P/E of -994.35x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Wockhardt | -1.95 | -0.58 | -3.45 | -19.52 | -7.35 | 82.80 | 25.37 |
| Sun Pharmaceutical Industries | 1.21 | -3.64 | 6.48 | 3.65 | -5.90 | 19.95 | 23.58 |
| Divi's Laboratories | -0.07 | -0.55 | 9.40 | -6.52 | 6.17 | 23.62 | 10.67 |
| Torrent Pharmaceuticals | 1.75 | 4.34 | 10.40 | 16.28 | 14.10 | 35.98 | 22.72 |
| Cipla | 1.10 | 0.90 | 0.39 | 0.87 | 0.75 | 12.26 | 12.83 |
| Dr. Reddy's Laboratories | -0.95 | -1.84 | 0.71 | -2.80 | -7.08 | 14.04 | 3.58 |
| Lupin | -0.25 | 1.30 | 6.88 | 7.78 | -10.98 | 41.87 | 15.45 |
| Zydus Lifesciences | 0.31 | -2.31 | -7.53 | -8.52 | -6.28 | 29.17 | 13.50 |
| Mankind Pharma | 0.55 | -0.09 | -10.00 | -6.74 | -24.99 | 15.71 | 9.15 |
| Aurobindo Pharma | 0.88 | 0.70 | 11.25 | 5.28 | -7.79 | 40.23 | 4.71 |
| Alkem Laboratories | 1.32 | -0.77 | 3.20 | 16.34 | 1.96 | 22.81 | 13.57 |
| Laurus Labs | 1.94 | 8.60 | 27.62 | 45.86 | 81.03 | 43.10 | 25.25 |
| Abbott India | -2.71 | -2.79 | -6.19 | -20.83 | -4.70 | 9.02 | 12.37 |
| Glenmark Pharmaceuticals | 3.14 | 5.45 | 4.76 | 16.28 | 26.71 | 68.52 | 32.22 |
| Biocon | 0.68 | -2.97 | 13.02 | 6.29 | 7.76 | 14.70 | -3.20 |
| GlaxoSmithKline Pharmaceuticals | -0.14 | -2.33 | -10.00 | -25.37 | 9.85 | 23.61 | 9.03 |
| Ajanta Pharma | 11.13 | 14.33 | 23.99 | 13.30 | 3.75 | 35.37 | 22.05 |
| Anthem Biosciences | 0.11 | -1.21 | -13.76 | -10.35 | -10.35 | -3.59 | -2.17 |
| Ipca Laboratories | -2.50 | -2.85 | 6.96 | -0.86 | -18.99 | 18.14 | 5.34 |
| J B Chemicals & Pharmaceuticals | 1.15 | 4.13 | 10.22 | 12.11 | -1.52 | 22.84 | 28.82 |
Over the last one year, Wockhardt has declined 7.35% compared to peers like Sun Pharmaceutical Industries (-5.90%), Divi's Laboratories (6.17%), Torrent Pharmaceuticals (14.10%). From a 5 year perspective, Wockhardt has outperformed peers relative to Sun Pharmaceutical Industries (23.58%) and Divi's Laboratories (10.67%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,415.18 | 1,416.44 |
| 10 | 1,424.85 | 1,411.69 |
| 20 | 1,384.55 | 1,395.68 |
| 50 | 1,356.17 | 1,386.18 |
| 100 | 1,408.49 | 1,409.6 |
| 200 | 1,460.43 | 1,396.3 |
In the latest quarter, Wockhardt remained same as its previous close in promoter holding, while DII stake unchanged at 11.00%, FII holding fell to 7.10%, and public shareholding moved up to 32.79% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 19,29,375 | 2.09 | 238.28 | |
| 13,25,150 | 1.01 | 163.66 | |
| 9,78,826 | 1.38 | 120.89 | |
| 8,37,752 | 0.69 | 103.46 | |
| 5,81,354 | 0.4 | 71.8 | |
| 5,75,064 | 0.79 | 71.02 | |
| 4,66,063 | 0.28 | 57.56 | |
| 4,51,605 | 0.28 | 55.77 | |
| 4,40,000 | 2.74 | 54.34 | |
| 3,92,954 | 0.1 | 48.53 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Jan 01, 2026, 11:10 PM IST | Wockhardt Ltd. - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 20 |
| Dec 31, 2025, 11:37 PM IST | Wockhardt Ltd. - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 20 |
| Dec 31, 2025, 10:02 PM IST | Wockhardt Ltd. - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order |
| Dec 31, 2025, 5:57 AM IST | Wockhardt Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Dec 16, 2025, 10:13 PM IST | Wockhardt Ltd. - Intimation For Incorporation Of Step-Down Subsidiaries Of The Company. |
Wockhardt Ltd. is a Public Limited Listed company incorporated on 08/07/1999 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24230MH1999PLC120720 and registration number is 120720. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1402.00 Cr. and Equity Capital is Rs. 81.00 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Wockhardt is ₹1,453.60 as on Jan 05, 2026.
The Wockhardt is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
The market cap of Wockhardt is ₹22,862.65 Cr as on Jan 05, 2026.
Today’s highest and lowest price of Wockhardt are ₹1,454.50 and ₹1,401.05.
The 52-week high/low is the highest and lowest price at which Wockhardt stock has traded in the past 52-week or nearly a year. The 52-week high of Wockhardt is ₹1,870.00 and 52-week low of Wockhardt is ₹1,109.60 as on Jan 05, 2026.
The Wockhardt has shown returns of 3.42% over the past day, 2.72% for the past month, -0.25% over 3 months, -4.28% over 1 year, 84.83% across 3 years, and 26.21% over 5 years.
P/E ratio of and PB ratio of Wockhardt are -994.35 and 5.01 on Jan 05, 2026. While the company gives a dividend yield of 0.00 per annum.